Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Aclaris Therapeutics (ACRS) Debt to Equity: 2017

  • Aclaris Therapeutics' Debt to Equity was N/A to $0.00 in Q4 2017 from the same period last year, while for Dec 2017 it was $0.00, marking a year-over-year change of. This contributed to the annual value of $0.00 for FY2017, which is N/A change from last year.
  • As of Q4 2017, Aclaris Therapeutics' Debt to Equity stood at $0.00.
  • Over the past 5 years, Aclaris Therapeutics' Debt to Equity peaked at $0.00 during Q4 2017, and registered a low of $0.00 during Q4 2017.
  • Over the past 1 years, Aclaris Therapeutics' median Debt to Equity value was $0.00 (recorded in 2017), while the average stood at $0.00.